Patent directory · USPTO A61K / A61P
Patents matching “Caribou Biosciences, Inc.”
19 pharma patents match "Caribou Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 19 pharmaceutical patents matching "Caribou Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11939604
Modified cascade ribonucleoproteins and uses thereof
granted -
US 11932703
Anti-ROR1 antibody and ROR1-targeting engineered cells
granted -
US 11472884
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 11312953
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 11299549
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 11142583
BCMA-CAR-natural killer (NK) cells and methods related thereto
granted -
US 11021542
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 10954498
Modified cascade ribonucleoproteins and uses thereof
granted -
US 10927182
Humanized BCMA antibody and BCMA-CAR-T cells
granted -
US 10711257
Modified cascade ribonucleoproteins and uses thereof
granted -
US 10435678
Modified cascade ribonucleoproteins and uses thereof
granted -
US 10125361
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9909122
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9885026
Modified cascade ribonucleoproteins and uses thereof
granted -
US 9809814
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9803194
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9725714
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 9410198
Compostions and methods of nucleic acid-targeting nucleic acids
granted -
US 9260752
Compositions and methods of nucleic acid-targeting nucleic acids
granted